Institutional
GSK plc (GSK, GLAXF)
CIK 0001131399
$599.2M
Reported AUM
13
Positions
Q1 2026
Period
2026-05-14
Filed
The Brief · GSK plc (GSK, GLAXF) · Q1 2026
AI · grounded in 13F
GSK plc closed its position in Senseonics Hldgs Inc SENS, reducing its holdings by $59,925. The fund also exited its position in Harvard Bioscience Inc HBIOUSD for a total of $7,458. These two divestments represent the only changes to a portfolio consisting of 13 positions with a total AUM of $599,153,380.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR THERAPEUTICS AG | $51.84 | -8.97% | 23.84% | -57.16% | $153.2M | 25.57% | — | HELD |
| 2 | WVE | WAVE LIFE SCIENCES LTD | $5.73 | -5.91% | -20.64% | 3.99% | $132.3M | 22.08% | — | HELD |
| 3 | BNTX | BIONTECH SE | $88.08 | -1.69% | -18.81% | -72.82% | $79.1M | 13.20% | — | HELD |
| 4 | VIR | VIR BIOTECHNOLOGY INC | $8.65 | -5.46% | 58.72% | -75.74% | $76.6M | 12.79% | — | HELD |
| 5 | IDYA | IDEAYA BIOSCIENCES INC | $28.29 | -3.18% | 30.19% | 15.47% | $44.4M | 7.41% | — | HELD |
| 6 | LYEL | LYELL IMMUNOPHARMA INC | $11.97 | -8.28% | -6.19% | -95.87% | $30.3M | 5.06% | — | HELD |
| 7 | CYTK | CYTOKINETICS INC | $71.48 | -1.12% | 121.30% | 140.84% | $22.4M | 3.74% | — | HELD |
| 8 | SPRO | SPERO THERAPEUTICS INC | $2.82 | -5.37% | 12.80% | -78.86% | $21.5M | 3.59% | — | HELD |
| 9 | FULC | FULCRUM THERAPEUTICS INC | $3.69 | 9.50% | -49.10% | -49.52% | $13.7M | 2.29% | — | HELD |
| 10 | CVRX | CVRX INC | $5.38 | -8.50% | -17.99% | -72.75% | $9.5M | 1.59% | — | HELD |
| 11 | BCYC | BICYCLE THERAPEUTICS PLC | $4.20 | -1.64% | -50.88% | -86.71% | $7.1M | 1.18% | — | HELD |
| 12 | NKTX | NKARTA INC | $2.51 | -9.39% | 32.11% | -92.10% | $6.6M | 1.11% | — | HELD |
| 13 | RGNX | REGENXBIO INC | $6.08 | -11.63% | -36.73% | -81.19% | $2.3M | 0.38% | — | HELD |
| 14 | SENS | SENSEONICS HLDGS INC | $6.67 | -4.85% | -36.72% | -89.14% | — | — | −10,856 | EXITED |
| 15 | HBIOUSD | HARVARD BIOSCIENCE INC | — | — | — | — | — | — | −11,151 | EXITED |
Source: SEC EDGAR · accession 0001999371-26-010742. 13F discloses long positions only — shorts, foreign equities, and options are excluded.